Fig 1: High expression levels of Sox5 and activation of the wnt/ß-catenin pathway in the hearts of patients with DCM. (A) Representative images of western blots of Sox5 and wnt/ß-catenin pathway-associated proteins (magnification, ×200) in human hearts. (B) Quantitative analysis of western blots. (C) Representative images of IHC staining of Sox5 and wnt-1 (magnification, ×400). (D) Quantitative analysis of IHC staining. n=6. *P<0.05; **P<0.01 vs. normal control. DCM, dilated cardiomyopathy; IHC, immunohistochemistry; WT, wild type; Dox, doxorubicin; p, phosphorylated.